Indeterminate thyroid nodules have a mild risk of malignancy (15-30%). The aim of our study is to individuate new biomarkers of thyroid carcinoma through multiomic analyses of blood samples and of specimen samples of patients with indeterminate thyroid nodules.
Patients with indeterminate thyroid nodules (Class III and Class IV according to Bethesda Classification of thyroid nodules)
Patients with concomitant thyroid nodules of Bethesda Class V or Class VI
Patients with preoperative diagnosis of lymph node metastases of central or lateral neck compartment
Patients with distant metastases
University of Cagliari
Lead sponsor
Prof. Pietro Giorgio Calò
Collaborator
Dott. Gian Luigi Canu
Collaborator